It appears that the problem of G6PD deficiency excludes many people from safe and effective treatment at the latent stage of vivax malaria, such as the G6PD-deficient persons, pregnant and lactating women, young infants, people with chronic hepatic problems, and a few others. Here, G6PD is linked to Plasmodium vivax malaria.